Decoy Therapeutics Inc. — Form 8-K
Filed September 15, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
Form 8-K filed 2026-09-15 reports Item 5.07 (Submission of Matters to a Vote of Security Holders) for period ending 2026-09-14. No specific vote details, counterparties, dollar amounts, or resolutions are disclosed in the provided filing text—only the procedural fact that matters were submitted to shareholders is confirmed.
Why this rating
Routine procedural disclosure of shareholder vote submission. No material transaction, financing, or strategic detail disclosed. Immaterial relative to $1.9M company scale.
Extracted items
See more from September 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.